Enter global pharmaceutical giants. US-based Eli Lilly and Novo Nordisk have both launched GLP-1-based treatments in India in ...

As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...

Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.

The Mounjaro weight-loss jab is now available from GPs the NHS, but only for a limited group of patients with a BMI over 35 ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Eli Lilly and Novo Nordisk intensify their weight-loss drug rivalry in India as rising demand and looming generics reshape a ...

UK health officials have launched a study into side-effects of weight loss drugs including Ozempic, Mounjaro and Wegovy ...

Eli Lilly said on Thursday that India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster ...

Eli Lilly said on Thursday India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster ...

Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli ...

Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term ...

Wegovy (semaglutide) and Mounjaro (tirzepatide) are prescription drugs that may be used for weight loss and management. But only Wegovy has been FDA-approved for this use. Mounjaro is approved to ...